Vinda International Holdings Ltd

Vinda International — Q1 2018 Earnings Presentation

11 slides from Vinda International's earnings presentation, May 2018

  1. Slide 1: Vinda International Holdings Limited 2018Q1 Results

    Vinda International Holdings Limited (Incorporated in the Cayman Islands with limited liability) (Stock code: 3331) 2018Q1 Results Investor Presentation

  2. Slide 2: Financial Highlights

    Financial Highlights (HK$M) 2018Q1 2017Q4 2017Q1 YOY Revenue 3,781 3,812 3,104 +21.8% Organic growth +11.7%1 +9.1%1 +7.0%2 Gross profit 1,077 1,065 945 +14.0% Gross margin 28.5% 27.9% 30.4% -1.9ppts Operating profit 331 224 293 +12.8% Operating margin 8.8% 5.9% 9.5% -0.7ppts EBITDA 570 449 480 +18.8

  3. Slide 3: Revenue

    Revenue Revenue (HK$M) Revenue Mix (%) YOY Reported Tissue Personal Care Growth (%) 19% 19% +21.8% 3,781 FY2017 2018Q1 3,104 2017Q1 2018Q1 81% 81% Revenue (HK$M) YOY Organic Growth1 (%) +8.5% +9.1% +11.7% +7.0% +6.7% +11.0% 13,486 3,367 3,812 3,781 3,104 3,203 2017 2017Q1 2017Q2 2017Q3 2017Q4 2018Q1

  4. Slide 4: Gross Profit

    Gross Profit Market List Price Gross Profit (HK$M) 18Q1 avg v.s. 17Q1 avg Long fiber: +46% USD/ton Short fiber: +38% +14.0% 1000 900 800 1,077 700 945 Long Fibre 600 Short Fibre 500 2017Q1 2018Q1 400 Gross Profit Margin (%) • Successful price hike • Product portfolio 29.7% 30.4% 30.6% 30.0% 27.9% 28

  5. Slide 5: Operating Profit

    Operating Profit Operating Profit (HK$M) • Good control over +12.8% administrative expense 331 • Effective management in 293 selling & marketing expense 2017Q1 2018Q1 Operating Profit Margin (%) 7.3% 9.5% 6.7% 7.4% 8.8% 5.9% 2017 2017Q1 2017Q2 2017Q3 2017Q4 2018Q1 5

  6. Slide 6: EBITDA

    EBITDA EBITDA (HK$M) +18.8% 570 480 2017Q1 2018Q1 EBITDA Margin (%) 13.4% 15.5% 15.1% 12.9% 13.7% 11.8% 2017 2017Q1 2017Q2 2017Q3 2017Q4 2018Q1 6

  7. Slide 7: Revenue by Channel

    Revenue by Channel 21% 21% 39% 38% FY2017 2018Q1 26% 27% 14% 14% 7

  8. Slide 8: Appendix

    Appendix 8

  9. Slide 9: Leading Market Positions

    Leading Market Positions Market share by region Tissue 17.7% No.1 Mainland China1 Inco 34% No.2 Taiwan, China3 Inco No.1 Malaysia4 55% 48% Tissue No.1 Hong Kong, China2 Baby No.1 Malaysia5 37% 71% Inco Tissue Fempro No.1 Singapore4 No.1 Malaysia6 31% 19% Baby Incontinence No.3 Singapore7 Note: Femin

  10. Slide 10: Disclaimer

    Disclaimer Information contained in our presentation is intended solely for your personal reference and is strictly confidential. Such information is subject to change without notice, its accuracy is not guaranteed and it may not contain all material information concerning the company and/or its bus

  11. Slide 11: Thank You

    Vinda Thank You Healthy Lifestyle \Stores with Vind

Vinda International Holdings — Q1 2018 Earnings Presentation on 6ix